Related Experiment Video
Updated: Jul 6, 2026

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells
Published on: February 2, 2024
Insulinlike growth factor I and the kidney
1Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, CA 90509, USA.
Insulin-like growth factor I (IGF-I) plays key roles in kidney repair and function, influencing nephron growth and filtration. Its complex interactions within the kidney are vital for maintaining renal health.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Insulin-like growth factor I (IGF-I), its receptors, and binding proteins are present in the nephron, suggesting local and systemic roles.
- IGF-I is implicated in compensatory nephron growth and tissue repair following kidney injury, such as ischemic acute tubular necrosis.
Purpose of the Study:
- To elucidate the multifaceted roles of IGF-I within the kidney.
- To investigate the impact of IGF-I on renal hemodynamics, tubular function, and its dysregulation in disease states.
Main Methods:
- The study reviews existing literature and experimental data on IGF-I expression and function in various kidney segments.
- Analysis of IGF-I's effects on glomerular filtration rate (GFR), tubular reabsorption, and its mediation by nitric oxide.
Main Results:
- IGF-I promotes arteriolar dilatation and increases GFR in experimental models, normal subjects, and chronic renal failure patients, likely via nitric oxide.
- IGF-I enhances proximal tubular phosphate reabsorption and potentially distal sodium absorption.
- In nephrotic syndrome, urinary excretion of IGF-I/IGF-binding protein complexes and increased IGFBP-3 protease activity indicate IGF-system dysregulation.
Conclusions:
- IGF-I is a critical factor in renal compensatory growth, repair, and functional regulation, acting through autocrine, paracrine, and endocrine mechanisms.
- Understanding IGF-I's renal actions and its alterations in conditions like nephrotic syndrome is crucial for potential therapeutic strategies.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Insulin: The Receptor and Signaling Pathways
Kidney Transplant I: Introduction
Oral Hypoglycemic Agents: Glinides
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Kidney Transplant III: Nursing Management